Krystal Biotech

Krish Krishnan, Chairman and CEO
Pittsburgh, PA
(NASDAQ: KRYS)
Krystal Biotech is a pivotal-stage gene therapy company leveraging its novel delivery platform to develop corrective, redosable therapies to address serious rare skin and lung diseases.

www.krystalbio.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions